Compounds > bicalutamide

bicalutamide and Drug Withdrawal Symptoms

bicalutamide has been researched along with Drug Withdrawal Symptoms in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (25.00)18.2507
2000's7 (58.33)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cowan, AJ; Inoue, Y; Yu, EY1
Fujii, M; Fujisawa, M; Ichikawa, T; Kumon, H; Matsuda, T; Matsumoto, T; Miki, T; Miyake, H; Miyoshi, S; Okihara, K; Ozono, S; Suzuki, H; Takihana, Y; Usui, T1
Fukui, I; Kawakami, S; Takeshita, H1
Inoue, T; Kamba, T; Kamoto, T; Maeno, A; Nakamura, E; Ogawa, O; Shimizu, Y; Terada, N; Yoshida, T1
OH, WK1
Araki, H; Hara, T; Kanzaki, N; Kusaka, M; Miyamoto, M; Miyazaki, J; Yamaoka, M1
Akakura, K; Ichikawa, T; Ito, H; Kojima, S; Shimbo, M; Suzuki, H1
Chapman, RA; Crawford, ED; Eisenberger, MA; Fontana, JA; Hussain, MH; Mills, GM; Parab, M; Raghavan, D; Sartor, AO; Tangen, CM1
Carroll, PR; Small, EJ1
Kolvenbag, GJ; Schellhammer, PF1
Nieh, PT1
El-Gabry, EA; Gomella, LG; Strup, SE1

Reviews

1 review(s) available for bicalutamide and Drug Withdrawal Symptoms

ArticleYear
Secondary hormonal therapies in the treatment of prostate cancer.
    Urology, 2002, Volume: 60, Issue:3 Suppl 1

    Topics: Adrenal Cortex Hormones; Androgen Antagonists; Anilides; Biomarkers, Tumor; Disease Progression; Estrogens; Humans; Male; Megestrol Acetate; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Tosyl Compounds

2002

Trials

1 trial(s) available for bicalutamide and Drug Withdrawal Symptoms

ArticleYear
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
    Cancer, 2008, Volume: 112, Issue:11

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Neoplasms; Disease-Free Survival; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Middle Aged; Nitriles; Orchiectomy; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Rate; Tosyl Compounds

2008

Other Studies

10 other study(ies) available for bicalutamide and Drug Withdrawal Symptoms

ArticleYear
Delayed antiandrogen withdrawal syndrome after discontinuation of bicalutamide.
    Clinical genitourinary cancer, 2015, Volume: 13, Issue:1

    Topics: Aged; Androgen Antagonists; Anilides; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Time Factors; Tosyl Compounds

2015
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
    The Journal of urology, 2008, Volume: 180, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Analysis; Tosyl Compounds; Treatment Outcome

2008
Profound bicalutamide withdrawal syndrome in a hormone-refractory T4N1 prostate cancer permitting both salvage radiotherapy and cessation of hormonal therapy.
    International journal of urology : official journal of the Japanese Urological Association, 2009, Volume: 16, Issue:3

    Topics: Aged; Androgen Antagonists; Anilides; Biopsy, Needle; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunohistochemistry; Male; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Conformal; Risk Assessment; Salvage Therapy; Substance Withdrawal Syndrome; Tosyl Compounds; Treatment Outcome

2009
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft.
    The Prostate, 2010, Feb-15, Volume: 70, Issue:3

    Topics: Administration, Oral; Androgen Antagonists; Androgens; Anilides; Animals; Antineoplastic Agents, Hormonal; Cysteine; Drug Administration Schedule; Flutamide; Humans; Male; Mice; Mutation; Neoplasm Transplantation; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Retreatment; Substance Withdrawal Syndrome; Tosyl Compounds; Transplantation, Heterologous; Tryptophan

2010
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
    Cancer research, 2003, Jan-01, Volume: 63, Issue:1

    Topics: Amino Acid Substitution; Androgen Antagonists; Anilides; Animals; Cell Division; Disease Models, Animal; DNA Primers; DNA, Complementary; Humans; Male; Mice; Mice, Nude; Mutagenesis, Site-Directed; Mutation; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Substance Withdrawal Syndrome; Tosyl Compounds; Transcription, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured

2003
Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy.
    The Journal of urology, 2004, Volume: 171, Issue:2 Pt 1

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Rate; Tosyl Compounds; Treatment Failure

2004
Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.
    Urology, 1994, Volume: 43, Issue:3

    Topics: Androgen Antagonists; Anilides; Humans; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Substance Withdrawal Syndrome; Tosyl Compounds

1994
Serum PSA decline after Casodex withdrawal.
    Urology, 1994, Volume: 44, Issue:5

    Topics: Anilides; Antineoplastic Agents; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Tosyl Compounds

1994
Withdrawal phenomenon with the antiandrogen casodex.
    The Journal of urology, 1995, Volume: 153, Issue:3 Pt 2

    Topics: Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Tosyl Compounds

1995
Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon.
    Techniques in urology, 2000, Volume: 6, Issue:3

    Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Goserelin; Humans; Male; Nitriles; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Tosyl Compounds

2000